相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics
Hanna Rosenmann et al.
EXPERIMENTAL NEUROLOGY (2008)
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
Z. Arvanitakis et al.
NEUROLOGY (2008)
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
Benjamin Wolozin et al.
BMC MEDICINE (2007)
Impact of HMG-CoA reductase inhibition on brain pathology
Frauke Zipp et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta(1-42) in the rat hippocampus in vivo
Rachael M. Clarke et al.
NEUROPHARMACOLOGY (2007)
Simvastatin enhances learning and memory independent of amyloid load in mice
Ling Li et al.
ANNALS OF NEUROLOGY (2006)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
Hanna Rosenmann et al.
ARCHIVES OF NEUROLOGY (2006)
Effects of statins on microglia
C Lindberg et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease
M Kitazawa et al.
JOURNAL OF NEUROSCIENCE (2005)
Statin use and the risk of incident dementia - The cardiovascular health study
TD Rea et al.
ARCHIVES OF NEUROLOGY (2005)
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia -: The Three-City Study
C Dufouil et al.
NEUROLOGY (2005)
Atorvastatin for the treatment of mild to moderate Alzheimer disease - Preliminary results
DL Sparks et al.
ARCHIVES OF NEUROLOGY (2005)
Basophilia, acidophilia and argyrophilia of dark (compacted) neurons during their formation, recovery or death in an otherwise undamaged environment
A Zsombok et al.
JOURNAL OF NEUROSCIENCE METHODS (2005)
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease
S Oddo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Do statins reduce risk of incident dementia and Alzheimer disease? The cache county study
PP Zandi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors attenuate β-amyloid-induced microglial inflammatory responses
A Cordle et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain
NB Chauhan et al.
NEUROCHEMICAL RESEARCH (2004)
Atorvastatin-induced activation of Alzheimer's α secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
S Parvathy et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis
A Schneider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia
XN Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Statin therapy and risk of dementia in the elderly - A community-based prospective cohort study
G Li et al.
NEUROLOGY (2004)
Association between statin use and Alzheimer's disease
E Zamrini et al.
NEUROEPIDEMIOLOGY (2004)
Lovastatin modulation of microglial activation via suppression of functional CD40 expression
KP Townsend et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Lovastatin enhances Aβ production and senile plaque deposition in female Tg2576 mice
IH Park et al.
NEUROBIOLOGY OF AGING (2003)
Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease
M Burns et al.
NEUROCHEMICAL RESEARCH (2003)
Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice
DJM Delsing et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
S Youssef et al.
NATURE (2002)
The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment
L Hajjar et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2002)
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people
K Rockwood et al.
ARCHIVES OF NEUROLOGY (2002)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
M van Heek et al.
DIABETES (2001)
Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration
K Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Turning blood into brain:: Cells bearing neuronal antigens generated in vivo from bone marrow
É Mezey et al.
SCIENCE (2000)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function
J Wardle et al.
AMERICAN JOURNAL OF MEDICINE (2000)
分享论文
